Oh, perfect. Thank you, Joy.
There was one question that I asked when we had some representatives from the ALS Society. When we look at the limited scope of the CHR funding, it's interesting to know how much is left off the table. I realize that there could be many projects that merit investment.
I understand that since 2000, there has been $70 million invested—I guess last year it was $9 million—in Parkinson's research. But how much has been applied for? And in your opinions, what amount of research that should be examined isn't being examined? Are we leaving a lot on the table?